Clinical Trial

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

Study acronym: AURORA
Recruiting
View on ClinicalTrials.gov →
Summary
The OBS19236 is a retrospective and prospective, non-interventional observational study in COPD patients treated with dupilumab as part of routine clinical care. It will follow-up about 350 to 500 participants over 36 months in up to 50 sites in France.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-01-28; most recent amendment 2026-04-13.
Trial Details
NCT Number NCT07380711
Lead Sponsor Sanofi
Conditions Chronic Obstructive Pulmonary Disease COPD
Enrollment 500 participants
Start Date 2026-01-28
Primary Completion 2030-08-14 (estimated)
Study Completion 2030-08-14 (estimated)
Updated on ClinicalTrials.gov 2026-04-14